News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambria Biosciences Announces Collaboration with Pfizer Animal Health in Antiparasitic Drug Discovery


6/7/2007 12:31:39 PM

WOBURN, Mass.--(BUSINESS WIRE)--Cambria Biosciences LLC, a Boston-area CNS drug discovery company, today announced a research collaboration agreement with Pfizer Animal Health to guide the discovery and development of new classes of safe and effective antiparasitic drug products. Cambria Biosciences will use its chemical genetics platform to elucidate the molecular targets — and important functional sites within those targets — that have responded to Pfizer’s candidate parasiticidal compounds. The compounds have potentially novel modes of action that could overcome the resistance that parasites have developed to many current medicines.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES